Naturalendo Tech Co., Ltd. (KOSDAQ: 168330)

Market Cap	47.20B
Revenue (ttm)	24.03B
Net Income (ttm)	-5.09B
Shares Out	31.57M
EPS (ttm)	-161.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,459
Open	1,501.00
Previous Close	1,496.00
Day's Range	1,460.00 - 1,501.00
52-Week Range	1,262.00 - 2,845.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 19, 2025

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacturing, and sale of physical chemistry and biology, biological agents, food additives, and health functional food in South Korea. The company offers vegetable female hormones, Wellmune immune booster, transdermal drug delivery system, microneedles, Derma A2 for the treatment of atopic dermatitis and acne, and other hormone-related materials. Naturalendo Tech Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2001
• Employees: 74
• Stock Exchange: KOSDAQ
• Ticker Symbol: 168330

Financial Performance

In 2023, Naturalendo Tech's revenue was 18.79 billion, an increase of 34.69% compared to the previous year's 13.95 billion. Losses were -4.37 billion, -56.68% less than in 2022.